AdamNathanGoldfarbMD
Pathology • Charlottesville, VAHematopathology, Anatomic Pathology, Clinical Pathology
Professor of Pathology, University VA School of Medicine
Are you Dr. Goldfarb?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 34 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1215 Lee St
Charlottesville, VA 22908Phone+1 888-882-3990Fax+1 434-243-6499
Summary
- Dr. Adam Goldfarb, MD is a board certified pathologist in Charlottesville, Virginia. He is currently licensed to practice medicine in Virginia, Ohio, and Minnesota. He is affiliated with University of Virginia Medical Center and is a Professor of Pathology at University VA School of Medicine.
Education & Training
University of MinnesotaResidency, Pathology-Anatomic and Clinical, 1986 - 1993- University of MinnesotaFellowship, Hematopathology, 1988 - 1989
Tufts University School of MedicineClass of 1986, MD
Certifications & Licensure
VA State Medical License 1998 - 2026
OH State Medical License 1993 - 1998
MN State Medical License 1987 - 1993- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 60 citationsIron control of erythroid development by a novel aconitase-associated regulatory pathwayGrant C. Bullock, Lorrie L. Delehanty, Anne Laure Talbot, Sara L. Gonias, Wing Hang Tong
Blood. 2010-07-08 - 234 citationsRUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiationKamaleldin E. Elagib, Frederick K. Racke, Michael Mogass, Rina Khetawat, Lorrie L. Delehanty
Blood. 2003-06-01 - 163 citationsSustained Activation of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Is Required for Megakaryocytic Differentiation of K562 Cells *Frederick K. Racke, Kristine Lewandowska, Said A. Goueli, Adam N. Goldfarb
The Journal of Biological Chemistry. 1997-09-12
Press Mentions
UVA Research May Improve Treatment of AnemiaApril 27th, 2021
Grant Support
- Preclinical Development Of A New Drug For Treating Anemia Of Chronic InflammationNational Institute On Aging2012
- Characterization Of A Novel Erythropoietin Signaling PathwayNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Iron Deficiency: Molecular And Cellular ConsequencesNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Involvement Of RUNX1 In Megakaryocytic DifferentiationNational Cancer Institute2008
- Involvement Of RUNX1 In Megakaryocytic DifferentiationNational Cancer Institute2003–2007
- Regulatory Pathways In Megakaryocyte DifferentiationNational Cancer Institute2002–2006
- Detailed Analysis Of Scl/Tal Dimerization With E ProteinNational Cancer Institute1998–2001
- Detailed Analysis Of Scl/Tal Dimerization With E ProteinNational Cancer Institute1997–1998
